Table 4.

Clinical characteristics of recipients with cGVHD (n = 8), recipients without cGVHD (n = 4), and healthy individuals (n = 3) included in the immunophenotypic analysis.

Groups	n	Age median	Individuals gender	Donor gender	Source of cells	Media time after HSCT
With cGVHD	8	37.2	Female = 2 (25%)	Female = 1 (12.5%)	BMSC = 2 (25%)	5 years and 8 months
			Male = 6 (75%)	Male = 7 (87.5%)	PBSC = 6 (75%)
Without cGVHD	4	41.5	Female = 3 (75%)	Female = 2 (50%)	BMSC = 4 (100%)	6 years and 1 month
			Male = 1 (25%)	Male = 2 (50%)	PBSC = 0
Healthy individuals	3	26.6	Female = 2 (66.7%)	—	—	—
			Male = 1 (33.3%)

BMSC: bone marrow stem cells; PBSC: peripheral blood stem cells.